Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum
出版年份 2014 全文链接
标题
Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 8, Pages 4642-4650
出版商
American Society for Microbiology
发表日期
2014-06-03
DOI
10.1128/aac.02783-14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
- (2013) Hon Wai Koon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnosis and Management of Clostridium difficile Infection
- (2013) Herbert L. DuPont Clinical Gastroenterology and Hepatology
- Treatment of recurrent Clostridium difficile infection: a systematic review
- (2013) J. C. O’Horo et al. INFECTION
- LPS-induced Inflammatory Response after Therapy of Aggressive Periodontitis
- (2013) L.M. Shaddox et al. JOURNAL OF DENTAL RESEARCH
- Host Gene Expression Profiling and In Vivo Cytokine Studies to Characterize the Role of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus (MRSA) Murine Sepsis Model
- (2013) Batu K. Sharma-Kuinkel et al. PLoS One
- Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury
- (2013) Laura Amado-Rodríguez et al. RESPIRATORY RESEARCH
- ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
- (2012) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
- (2012) T. J. Louie et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Inhibits Spore Production in Clostridium difficile
- (2012) Farah Babakhani et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
- (2012) Irina Artsimovitch et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- The antimicrobial peptide cathelicidin modulatesClostridium difficile-associated colitis and toxin A-mediated enteritis in mice
- (2012) Tressia C Hing et al. GUT
- Fidaxomicin inhibits toxin production in Clostridium difficile
- (2012) F. Babakhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea
- (2012) Yoav Golan et al. Therapeutic Advances in Gastroenterology
- Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection
- (2011) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin
- (2011) Sean T. Duggan DRUGS
- Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells
- (2011) Solen Pichereau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen
- (2011) Yoko Hiwatashi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Advances in pathogenesis, diagnosis and management of CDI
- (2011) Dale N. Gerding et al. Nature Reviews Gastroenterology & Hepatology
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fidaxomicin: A Macrocyclic Antibiotic for the Treatment ofClostridium difficileInfection
- (2011) Jennifer S Hardesty et al. PHARMACOTHERAPY
- Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells
- (2010) Antonietta Rizzo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
- (2010) G. W. Tannock et al. MICROBIOLOGY-SGM
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
- (2009) Stuart Johnson JOURNAL OF INFECTION
- Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses
- (2008) Y. K. Shue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search